Literature DB >> 9067642

Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.

E Buratti1, M Di Michele, P Song, C Monti-Bragadin, E A Scodeller, F E Baralle, S G Tisminetzky.   

Abstract

Recent studies have identified several epitopes in the N-terminal portion of the nucleocapsid protein which are predominantly recognized by sera of patients infected with hepatitis C virus (HCV). The characterization of the sequences recognized by theses antibodies and the evaluation of their reactivities have been performed mainly with synthetic peptides. However, synthetic peptides are notoriously unreliable as antigens when the immune response is directed against conformational epitopes. In order to improve the detection of antibody responses in HCV-infected patients, we have evaluated the reactivities of three immunodominant regions of the HCV core protein (residues 1 to 20, 21 to 40, and 32 to 46) displayed in a conformation-specific manner on the surface of the Flock House virus (FHV) capsid protein. The results obtained with these proteins in the analysis of 94 serum samples positive by anti-HCV enzyme-linked immunosorbent assay where then compared with those obtained with the corresponding synthetic peptides. The sequence most reactive both with the peptide and with the FHV protein was the region from residues 1 to 20, confirming the low conformational requirements for the display of these residues. On the other hand, the already reported conformational nature of residues 32 to 46 is in keeping with its observed high reactivity when displayed by the FHV recombinant protein and with the low reactivity displayed by its corresponding synthetic peptide. Finally, the high reactivity observed for the chimeric protein displaying the region from residues 21 to 40, as opposed to the results obtained with the synthetic peptide, also suggests that this sequence contains one or more conformational epitopes whose structures cannot be mimicked correctly with synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067642      PMCID: PMC170488          DOI: 10.1128/cdli.4.2.117-121.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  32 in total

Review 1.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

2.  Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains.

Authors:  M Schutten; J P Langedijk; A C Andeweg; R C Huisman; R H Meloen; A D Osterhaus
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.

Authors:  T Miyamura; I Saito; T Katayama; S Kikuchi; A Tateda; M Houghton; Q L Choo; G Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  A blocking agent and a blocking step are not needed in ELISA, immunostaining dot-blots and western blots.

Authors:  K Mohammad; A Esen
Journal:  J Immunol Methods       Date:  1989-02-08       Impact factor: 2.303

5.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Identification of an immunodominant epitope within the capsid protein of hepatitis C virus.

Authors:  M S Nasoff; S L Zebedee; G Inchauspé; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen.

Authors:  T Katayama; T Mazda; S Kikuchi; S Harada; Y Matsuura; J Chiba; H Ohba; I Saito; T Miyamura
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  3 in total

1.  Expression and immunoreactivity of HCV/HBV epitopes.

Authors:  Xin-Yu Xiong; Xiao Liu; Yuan-Ding Chen
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 2.  Recent insights into the biology and biomedical applications of Flock House virus.

Authors:  P A Venter; A Schneemann
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

Review 3.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.